Markus M. Weck

1.7k citations

18 papers · 1.4k · h-index 18

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Hematology top 5%
- Chronic Myeloid Leukemia Treatments

Papers in

Immunology 14
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- Immune Response and Inflammation 4
Molecular Biology 6
- RNA Interference and Gene Delivery 4

Co-authors: Peter Brossart (16 shared papers)Frank Grünebach (15 shared papers)Silke Appel (11 shared papers)Martin Müller (6 shared papers)Anita Bringmann (6 shared papers)Lothar Kanz (3 shared papers)Susanne M. Schmidt (3 shared papers)Daniela Werth (3 shared papers)
Journals: Blood (8 papers)Leukemia (3 papers)Clinical Cancer Research (2 papers)Cancer Gene Therapy (1 paper)Experimental Hematology (1 paper)
Partner nations: Germany Switzerland Belgium

In The Last Decade

Markus M. Weck

18 papers receiving 1.4k citations

Peers

Countries citing papers authored by Markus M. Weck

Since Specialization

Citations

This map shows the geographic impact of Markus M. Weck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus M. Weck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus M. Weck more than expected).

Fields of papers citing papers by Markus M. Weck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus M. Weck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus M. Weck. The network helps show where Markus M. Weck may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus M. Weck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus M. Weck Line = papers co-authored together Markus M. Weck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells Blood ·Susanne M. Schmidt, Kerstin Schag, Martin Müller, Markus M. Weck, Silke Appel, Lothar Kanz, Frank Grünebach, Peter Brossart	2003	209
2	PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways Blood ·Silke Appel, Valdete Mirakaj, Anita Bringmann, Markus M. Weck, Frank Grünebach, Peter Brossart	2005	163
3	Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNA Blood ·Daniela Dörfel, Silke Appel, Frank Grünebach, Markus M. Weck, Martin Müller, Annkristin Heine, Peter Brossart	2004	142
4	Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells Blood ·Silke Appel, Andreas M. Boehmler, Frank Grünebach, Martin Müller, Anette Rupf, Markus M. Weck, Ulrike Hartmann, Volker L. Reichardt, Lothar Kanz, Tim H. Brümmendorf, Peter Brossart	2003	133
5	CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells Blood ·Adriana R. Mantegazza, María Marcela Barrio, Sandrine Moutel, Laura Bover, Markus M. Weck, Peter Brossart, Jean‐Luc Teillaud, José Mordoh	2004	109
6	TLR ligands differentially affect uptake and presentation of cellular antigens Blood ·Markus M. Weck, Frank Grünebach, Daniela Werth, Christian Sinzger, Anita Bringmann, Peter Brossart	2007	82
7	Molecular and functional characterization of human Dectin-1 Experimental Hematology ·Frank Grünebach, Markus M. Weck, Jeannette Reichert, Peter Brossart	2002	78
8	Furan and Methylfurans in Foods: An Update on Occurrence, Mitigation, and Risk Assessment Comprehensive Reviews in Food Science and Food Safety ·Beate Kettlitz, Gabriele Scholz, Viviane Theurillat, Jörg Cselovszky, Neil Buck, Sue O’ Hagan, Eva Mavromichali, Katja Ahrens, Karin Kraehenbuehl, Gabriella Scozzi, Markus M. Weck, Claudia Vinci, Marta Sobieraj, Richard H. Stadler	2019	71
9	hDectin-1 is involved in uptake and cross-presentation of cellular antigens Blood ·Markus M. Weck, Silke Appel, Daniela Werth, Christian Sinzger, Anita Bringmann, Frank Grünebach, Peter Brossart	2007	69
10	Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle Leukemia ·Stefan Horn, Elmar Endl, Boris Fehse, Markus M. Weck, Georg W. Mayr, Manfred Jücker	2004	62
11	Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-κB and Akt Signaling Pathways Clinical Cancer Research ·Silke Appel, Anette Rupf, Markus M. Weck, Oliver Schoor, Tim H. Brümmendorf, Toni Weinschenk, Frank Grünebach, Peter Brossart	2005	61
12	Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis Cancer Research ·Susanne M. Schmidt, Kerstin Schag, Martin Müller, Toni Weinschenk, Silke Appel, Oliver Schoor, Markus M. Weck, Frank Grünebach, Lothar Kanz, Stefan Stevanović, Hans‐Georg Rammensee, Peter Brossart	2004	51
13	Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes Cancer Gene Therapy ·Frank Grünebach, Katrin Kayser, Markus M. Weck, Martin Müller, Silke Appel, Peter Brossart	2005	48
14	Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes Clinical Cancer Research ·Kerstin Schag, Susanne M. Schmidt, Martin Müller, Toni Weinschenk, Silke Appel, Markus M. Weck, Frank Grünebach, Stefan Stevanović, Hans‐Georg Rammensee, Peter Brossart	2004	32
15	Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells Leukemia ·Anja Knödler, Sebastian Schmidt, Anita Bringmann, Markus M. Weck, Katharina M. Brauer, Tobias A.W. Holderried, A-K Heine, Frank Grünebach, Peter Brossart	2008	31
16	Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells Leukemia ·Anita Bringmann, Sebastian Schmidt, Markus M. Weck, Katharina M. Brauer, Karin von Schwarzenberg, Daniela Werth, Frank Grünebach, Peter Brossart	2007	31
17	Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell Responses Molecular Therapy ·Annkristin Heine, Frank Grünebach, Tobias A.W. Holderried, Silke Appel, Markus M. Weck, Daniela Dörfel, Christian Sinzger, Peter Brossart	2005	23
18	Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs Blood ·Silke Appel, Anita Bringmann, Frank Grünebach, Markus M. Weck, Jürgen Bauer, Peter Brossart	2005	17

About Markus M. Weck

Markus M. Weck is a scholar working on Immunology, Molecular Biology, Epidemiology, Hematology and Cancer Research, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers), RNA Interference and Gene Delivery (4 papers), Immune Response and Inflammation (4 papers), Cytomegalovirus and herpesvirus research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Immunology (765 citations), Hematology (174 citations), Genetics (111 citations), Oncology (254 citations) and Immunology and Allergy (56 citations). Markus M. Weck has collaborated with scholars based in Germany, Switzerland and Belgium. Frequent co-authors include Peter Brossart, Frank Grünebach, Silke Appel, Martin Müller, Anita Bringmann, Lothar Kanz, Susanne M. Schmidt, Daniela Werth, Christian Sinzger and Annkristin Heine. Their work appears in journals such as Blood, Leukemia, Clinical Cancer Research, Cancer Gene Therapy and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Markus M. Weck

Impact in

Papers in i

In The Last Decade

Markus M. Weck

Peers

Countries citing papers authored by Markus M. Weck

Fields of papers citing papers by Markus M. Weck

All Works

About Markus M. Weck

Explore authors with similar magnitude of impact

Papers in